Keith Kennedy was named Chief Financial Officer and Chief Operating Officer of CareDx, Inc., succeeding Nathan Smith, effective February 26, 2026. As of November 14, 2026, CareDx, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 25, 2026, naming 1 appointment and 1 departure (Form 8-K, February 25, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like CareDx, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
CareDx, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-25. It names 2 people, with 1 appointment and 1 departure. Every row below is cited to the filing it comes from, and this page adds each new change as CareDx, Inc. files it.
Also on the record for CareDx, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| November 10, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.1% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by Baron Capital Group, Inc. | 3.75% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 4.8% of the class | 5%+ stakes | Source |
| August 7, 2026 | Stake report, Schedule 13G/A, by Neil Gagnon | 4.4% of the class | 5%+ stakes | Source |
| July 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 9% of the class | 5%+ stakes | Source |
| July 7, 2026 | Acquired Naveris, Inc. | — | Acquisition | Source |
| July 1, 2026 | Acquired Naveris, Inc. | $171.70M | Acquisition | Source |
| March 26, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G/A, by Neil Gagnon | 5.9% of the class | 5%+ stakes | Source |
| February 9, 2026 | Stake report, Schedule 13G, by STATE STREET CORPORATION | 5.3% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G, by Baron Capital Group, Inc. | 5.93% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 7.04% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs CareDx, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on CareDx, Inc. and the records around it.
CareDx, Inc. elsewhere on the record
- 5%+ stake filings Nov 2026
- Acquisition Sep 2026
- Who owns it
Companies that share a holder
- Gagnon Securities LLC also filed stake reports on 4 other companies: CNFinance Holdings Ltd. (Nov 2026), Ameresco, Inc. (Aug 2026), Kaltura, Inc. (Aug 2026)
- BAMCO INC /NY/ also filed stake reports on 22 other companies: Birkenstock Holding plc (Aug 2026), Blackstone Digital Infrastructure Trust Inc. (Aug 2026), Choice Hotels International, Inc. (Aug 2026)
- STATE STREET CORPORATION also filed stake reports on 378 other companies: 4D MOLECULAR THERAPEUTICS INC (Nov 2026), ACADIA PHARMACEUTICALS INC (Nov 2026), ALBEMARLE CORP (Nov 2026)
Watch CareDx, Inc.
Get an email when CareDx, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on CareDx, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on CareDx, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on CareDx, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 13 records.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-25 | In | Chief Financial Officer and Chief Operating Officer | 2026-02-26 | 8-K/A, 2026-02-25 | |
| 2026-02-25 | Out | Chief Financial Officer | 2026-02-25 | 8-K/A, 2026-02-25 |
Why did they leave? What the filings say
For each named departure below, the sentence from the company's own filing that gives a reason, word for word. Where a filing gives none, it says so here; nothing is inferred.
- Nathan Smith, Chief Financial Officer (filed 2026-02-25):
The conclusion of Mr. Smith's employment is not a result of any disagreement regarding the Company's financial statements or disclosures.
Who leads CareDx, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Financial Officer and Chief Operating Officer: Keith Kennedy, appointed, effective 2026-02-26 (filed 2026-02-25).
- Chief Financial Officer: Nathan Smith, departure reported, effective 2026-02-25 (filed 2026-02-25). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on CareDx, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Financial Officer and Chief Operating Officer at CareDx, Inc., with the record behind each one.
Find candidates like Chief Financial Officer and Chief Operating Officer at CareDx, Inc.Every change, in the filing's words
Appointed: Keith Kennedy, Chief Financial Officer and Chief Operating Officer, effective 2026-02-26
The Board of Directors of the Company has appointed Keith Kennedy as the Company's Chief Financial Officer and Chief Operating Officer, effective as of February 26, 2026.
Departing: Nathan Smith, Chief Financial Officer, effective 2026-02-25
On February 24, 2026, the Company announced Nathan Smith resigned from his position as the Company's Chief Financial Officer for personal reasons, effective as of the close of business on February 25, 2026 (the "Separation Date").
- In connection with such appointment, Mr. Kennedy has also been designated as the Company's "principal financial officer" and "principal accounting officer" for purposes under the Securities Exchange Act of 1934, as amended.
- Mr. Kennedy, age 56, has served as the Company's Chief Operating Officer since September 2024.
- Prior to joining the Company, Mr. Kennedy served as the Chief Financial Officer of PharmaLogic Holdings Corp from April 2022 to September 2024.
- Mr. Kennedy served as Veractye, Inc.'s Chief Operating Officer from July 2019, as well as its Chief Financial Officer from December 2016, until his retirement in May 2021, as well as its Secretary from November 2017 to July 2020.
- Prior to joining Veracyte, Mr. Kennedy provided strategic counsel and consulting services from his consulting practice from September 2015 to November 2016, including advisory services to Pennant Park Investment Advisors.
- Mr. Kennedy served as President, Chief Executive Officer and Director of MCG Capital Corporation, a publicly traded business development company, from April 2014 until its merger with Pennant Park Floating Rate Capital Ltd in August 2015.
- Mr. Kennedy joined MCG Capital Corporation in February 2012 as an Executive Vice President and Managing Director, served as its Chief Financial Officer and Treasurer from May 2012 to March 2014, and its President from March to April 2014.
Tools for this story
Each opens in a new tab, filled in for CareDx, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
